CAPOZIDE 50 Drug Patent Profile
✉ Email this page to a colleague
When do Capozide 50 patents expire, and when can generic versions of Capozide 50 launch?
Capozide 50 is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in CAPOZIDE 50 is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capozide 50
A generic version of CAPOZIDE 50 was approved as captopril; hydrochlorothiazide by RISING on December 29th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAPOZIDE 50?
- What are the global sales for CAPOZIDE 50?
- What is Average Wholesale Price for CAPOZIDE 50?
Summary for CAPOZIDE 50
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CAPOZIDE 50 at DailyMed |
US Patents and Regulatory Information for CAPOZIDE 50
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | CAPOZIDE 50/15 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-004 | Oct 12, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | CAPOZIDE 50/25 | captopril; hydrochlorothiazide | TABLET;ORAL | 018709-003 | Oct 12, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
